The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia von Allen, C, Hills, R K, Lamb, K, Evans, C, Tinsley, S, Sellar, R, O'Brien, M, Yin, J L, Burnett, A K, Linch, D C, Gale, R E

Volltext

Correction: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways von Grandage, V. L., Gale, R. E., Linch, D. C., Khwaja, A.

Volltext

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation von Thomson, K J, Peggs, K S, Smith, P, Cavet, J, Hunter, A, Parker, A, Pettengell, R, Milligan, D, Morris, E C, Goldstone, A H, Linch, D C, Mackinnon, S

Volltext

Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment von SWERDLOW, A. J, BARBER, J. A, HUDSON, G. V, CUNNINGHAM, D, GUPTA, R. K, HANCOCK, B. W, HORWICH, A, LISTER, T. A, LINCH, D. C

Volltext

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial von Ardeshna, KM, Smith, P, Norton, A, Hancock, BW, Hoskin, PJ, MacLennan, KA, Marcus, RE, Jelliffe, A, Hudson, G Vaughan, Linch, DC

Volltext

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors von Cooke, R, Jones, M E, Cunningham, D, Falk, S J, Gilson, D, Hancock, B W, Harris, S J, Horwich, A, Hoskin, P J, Illidge, T, Linch, D C, Lister, T A, Lucraft, H H, Radford, J A, Stevens, A M, Syndikus, I, Williams, M V, Swerdlow, A J

Volltext

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial von McMillan, A.K., Phillips, E.H., Kirkwood, A.A., Barrans, S., Burton, C., Rule, S., Patmore, R., Pettengell, R., Ardeshna, K.M., Lawrie, A., Montoto, S., Paneesha, S., Clifton-Hadley, L., Linch, D.C.

Volltext

Central nervous system chemoprophylaxis in non‐Hodgkin lymphoma: current practice in the UK von Cheung, C. W., Burton, C., Smith, P., Linch, D. C., Hoskin, P. J., Ardeshna, K. M.

Volltext

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients von Schmitz, N, Dreger, P, Linch, D.C, Goldstone, A.H, Boogaerts, M.A, Demuynck, H.M.S, Ferrant, A, Zander, A, Link, H, Barge, A, Borkett, K

Volltext

Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial von Jenkinson, S, Kirkwood, A A, Goulden, N, Vora, A, Linch, D C, Gale, R E

Volltext

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial von Linch, D.C., Goldstone, A.H., McMillan, A., Chopra, R., Vaughan Hudson, G., Winfield, D., Hancock, B., Moir, D., Milligan, D.

Volltext

Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment von SWERDLOW, A. J, SCHOEMAKER, M. J, LINCH, D. C, ALLERTON, R, HORWICH, A, BARBER, J. A, CUNNINGHAM, D, LISTER, T. A, ROHATINER, A. Z. S, HUDSON, G. Vaughan, WILLIAMS, M. V

Volltext

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma von MILLS, W, CHOPRA, R, MCMILLAN, A, PEARCE, R, LINCH, D. C, GOLDSTONE, A. H

Volltext

Primary sciatic nerve lymphoma: a case report and review of the literature von Descamps, M J L, Barrett, L, Groves, M, Yung, L, Birch, R, Murray, N M F, Linch, D C, Lunn, M P T, Reilly, M M

Volltext

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis von Bowen, D, Groves, M J, Burnett, A K, Patel, Y, Allen, C, Green, C, Gale, R E, Hills, R, Linch, D C

Volltext

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL) von Betticher, DC, Martinelli, G, Radford, JA, Kaufmann, M, Dyer, MJS, Kaiser, U, Aulitzky, WE, Beck, J, von Rohr, A, Kovascovics, T, Cogliatti, SB, Cina, S, Maibach, R, Cerny, T, Linch, DC

Volltext

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial von Jenkinson, S, Koo, K, Mansour, M R, Goulden, N, Vora, A, Mitchell, C, Wade, R, Richards, S, Hancock, J, Moorman, A V, Linch, D C, Gale, R E

Volltext

High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia von Mansour, M R, Linch, D C, Foroni, L, Goldstone, A H, Gale, R E

Volltext

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting f... von WATTS, M. J, SULLIVAN, A. M, JAMIESON, E, PEARCE, R, FIELDING, A, DEVEREUX, S, GOLDSTONE, A. H, LINCH, D. C

Volltext

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in pati... von SMITH, T. J, HILLNER, B. E, YANOVICH, S, KITCHIN, R, ERDER, M. H, SCHMITZ, N, LINCH, D. C, DREGER, P, GOLDSTONE, A. H, BOOGAERTS, M. A, FERRANT, A, LINK, H, ZANDER, A

Volltext